Sylvain Gabriel Goutebroze

Title: Sylvain Gabriel Goutebroze: Innovator in Bacterial Mutations

Introduction

Sylvain Gabriel Goutebroze is a notable inventor based in Lyons, France. He has made significant contributions to the field of microbiology, particularly in the development of attenuated gram-negative bacteria. With a total of 4 patents to his name, Goutebroze's work has implications for immunogenic compositions and vaccines.

Latest Patents

Goutebroze's latest patents focus on the disclosure and claims of a mutant of a gram-negative bacterium. This bacterium has at least one mutation in a nucleotide sequence that codes for a polypeptide with a high degree of identity to specific amino acid sequences. The mutations result in attenuated virulence, making these bacteria suitable for use in immunogenic compositions and vaccines. His work in this area is crucial for advancing vaccine development and improving public health.

Career Highlights

Goutebroze is currently associated with Merial Limited, a company known for its innovations in animal health. His research and inventions have contributed to the understanding of bacterial mutations and their applications in immunology. His expertise in this niche area of microbiology has positioned him as a valuable asset in the field.

Collaborations

Some of Goutebroze's notable coworkers include Helen Rachel Crooke and Jacqueline Elizabeth Shea. Their collaborative efforts have likely enhanced the research and development processes within their projects.

Conclusion

Sylvain Gabriel Goutebroze's work in the field of attenuated gram-negative bacteria represents a significant advancement in vaccine technology. His contributions continue to influence the landscape of immunology and public health.